2,6-Difluorobenzaldehyde → HCID 60071901, Verbindung

HRID 23290

Reaktionsgleichung

Reaktionsgleichung von HRID 23290
[F:1][C:2]1[CH:9]=[CH:8][CH:7]=[C:6]([F:10])[C:3]=1[CH:4]=O.[NH2:11][C:12]1[CH:13]=[C:14]2[C:18]3=[C:19]([CH2:21][S:22][CH2:23][CH2:24][N:17]3[C@H:16]3[CH2:25][CH2:26][N:27](C(OC(C)(C)C)=O)[CH2:28][C@@H:15]23)[CH:20]=1>>[F:1][C:2]1[CH:9]=[CH:8][CH:7]=[C:6]([F:10])[C:3]=1[CH2:4][NH:11][C:12]1[CH:13]=[C:14]2[C:18]3=[C:19]([CH2:21][S:22][CH2:23][CH2:24][N:17]3[C@H:16]3[CH2:25][CH2:26][NH:27][CH2:28][C@@H:15]23)[CH:20]=1

Komponenten

3

Edukt 2

HCID 1362842,6-DifluorobenzaldehydeHCID 86586437tert-butyl (7bR,11aS)-6-amino-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H) carboxylate

Produkt 1

HCID 60071901HCID 60071901, Verbindung

Versuchsvorschrift

Using 2,6-difluorobenzaldehyde and following the procedures described in EXAMPLE 126, tert-butyl (7bR,11aS)-6-amino-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H)-carboxylate from EXAMPLE 33, Part B was converted into the title compound of EXAMPLE 161. 1H NMR (CDCl3) δ: 7.23-7.15 (m, 1H), 6.88-6.80 (m, 2H), 6.42 (s, 1H), 6.28 (s, 1H), 4.31 (broad s, 2H), 3.64 (s, 2H), 3.55-3.45 (m, 1H), 3.37-3.23 (m, 2H), 3.15-2.80 (m, 6H), 2.60-2.50 (m, 1H), 2.05-1.82 (m, 2H). LRMS (ES)+: 388.4 (M+H)+.

Quellen und Nachweise

ORD-Eintrag
ord-0da7b9dc6c1948afb1bfa26633b16135
Quelldatensatz
uspto-grants-2005_02
Patentnummer
US06849619B2

Verknüpfte Notizen

Wird geladen…